Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susanna Gatti High currently holds 131,636 shares of Dyne Therapeutics, Inc. (DYN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susanna Gatti High has been a net seller of DYN stock. They have purchased $0 and sold $13.6M worth of shares.
Susanna Gatti High's most recent insider trade was on Sep 18, 2024, when they sold 4,636 shares at $34.41 per share.
Susanna Gatti High serves as Executive at Dyne Therapeutics, Inc. (DYN). They have executed 77 insider transactions totaling $13.6M over their tenure at the company.
Susanna Gatti High holds the position of Executive at Dyne Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Susanna Gatti High has shown a selling trading pattern, with $0 in total purchases and $13.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Susanna Gatti High was on Jun 10, 2024, when they sold $2.4M worth of DYN shares. This transaction involved 80,000 shares at $30.24 per share.
Susanna Gatti High currently owns 131,636 shares of Dyne Therapeutics, Inc. (DYN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susanna Gatti High's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susanna Gatti High has 77 Form 4 filings on record as an insider at Dyne Therapeutics, Inc..
Set alerts for Susanna Gatti High and 40,000+ other insiders.